Logo

American Heart Association

  37
  0


Final ID:

What do I do with all this uncertainty?

  • Hespe, Sophie  ( UNSW Sydney , Sydney , New South Wales , Australia )
  • Pereira, Naveen  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Day, Sharlene  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Ezekian, Jordan  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Author Disclosures:
    Sophie Hespe: DO NOT have relevant financial relationships | Naveen Pereira: No Answer | Sharlene Day: DO have relevant financial relationships ; Consultant:Lexicon Pharmaceuticals:Active (exists now) ; Research Funding (PI or named investigator):BMS:Active (exists now) ; Consultant:Solid Biosciences:Active (exists now) ; Advisor:Cytokinetics:Active (exists now) ; Research Funding (PI or named investigator):Lexicon Pharmaceuticals:Active (exists now) | Jordan Ezekian: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

I Ordered Genetic Testing: Now What?

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Can deep clinical phenotyping resolve uncertainty for my patient?

Arbustini Eloisa, Ware James, Elliott Perry, Day Sharlene

How does family history help with resolving uncertainty?

Hershberger Ray, Bondue Antoine, Wheeler Matthew

More abstracts from these authors:
Hypertrophic Cardiomyopathy

Day Sharlene

What do I do with all these secondary findings?

Landstrom Andrew, Pereira Naveen, Ezekian Jordan

You have to be authorized to contact abstract author. Please, Login
Not Available